Tessa Van Der Kolk-Niemeyer
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Lost and found in translation: the value of the human imiquimod model.
Journal: British journal of clinical pharmacology
Published: April 02, 2026
Interpretation of Chemistry, Hematology and Coagulation Laboratory Results in Early-Phase Clinical Pharmacology Trials; a Retrospective Analysis Based on the Placebo Arm of Randomized-Controlled Trials.
Journal: Clinical and translational science
Published: February 09, 2026
S. aureus colonization and clinical symptoms remain stable upon topical XZ.700 treatment: Results of a double-blind randomized clinical trial in patients with mild to moderate atopic dermatitis.
Journal: British journal of clinical pharmacology
Published: November 07, 2025
Lack of improvement after short-term topical antistaphylococcal endolysin SA.100 therapy in patients with mild-to-moderate atopic dermatitis: Results from a randomized, vehicle-controlled trial.
Journal: British journal of clinical pharmacology
Published: July 25, 2025
Multi-omics profiling of chronic immune-mediated skin diseases: SKINERGY protocol and strategic evaluation.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 30, 2025
Guselkumab treatment normalizes the stratum corneum ceramide profile and alleviates barrier dysfunction in psoriasis: results of a randomized controlled trial.
Journal: Journal of lipid research
Published: April 24, 2024
Similar Alterations of the Stratum Corneum Ceramide Profile in Atopic Dermatitis, Psoriasis, and Ichthyosis: Results from a Systematic Review and Meta-Analysis.
Journal: The Journal of investigative dermatology
Published: December 11, 2023
Immunomodulating effects of the single bacterial strain therapy EDP1815 on innate and adaptive immune challenge responses - a randomized, placebo-controlled clinical trial.
Journal: Immunologic research
Published: November 20, 2023
Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept Trial.
Journal: International journal of molecular sciences
Published: August 26, 2023
Guselkumab induction therapy demonstrates long-lasting efficacy in patients with mild psoriasis, results from a randomized, placebo-controlled exploratory clinical trial.
Journal: Journal of the American Academy of Dermatology
Published: August 22, 2023
Lesional skin of seborrheic dermatitis patients is characterized by skin barrier dysfunction and correlating alterations in the stratum corneum ceramide composition.
Journal: Experimental dermatology
Published: June 22, 2023
Oral prednisolone suppresses skin inflammation in a healthy volunteer imiquimod challenge model.
Journal: Frontiers in immunology
Published: March 31, 2023
Last Updated: 09/26/2026